Faeth Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-16.0M | $-170.2M | $-4.6M | $-4.9M | $-6.9M | $-7.3M | $-7.1M | $-8.0M |
| Depreciation & Amortization | — | $29.0K | — | — | $30.0K | $140.0K | $135.0K | $137.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $12.9M | — | — | $461.0K | — | — | $1.2M |
| Net Cash from Operating Activities | $-15.7M | $-10.7M | $-3.6M | $-5.9M | $-7.1M | $-5.5M | $-5.8M | $-7.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $6.0K | $0 | $16.0K | $0 | $0 | $109.0K | $37.0K |
| Business Acquisitions | — | $-6.5M | — | — | $0 | — | — | — |
| Net Cash from Investing Activities | — | $-31.4M | — | — | $7.2M | — | — | $5.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $185.8M | — | — | $-214.0K | — | — | $-209.0K |
| Net Change in Cash | — | $143.7M | — | — | $-117.0K | — | — | $-2.1M |
| Free Cash Flow | $-15.7M | $-10.7M | $-3.6M | $-5.9M | $-7.1M | $-5.5M | $-5.9M | $-7.7M |